Santin A D, Hermonat P L, Ravaggi A, Bellone S, Roman J, Pecorelli S, Cannon M, Parham G P
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205-7199, USA.
Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):997-1006. doi: 10.1016/s0360-3016(00)00769-0.
To compare the effects of concurrent administration of cisplatinum (40 mg/m(2)/weekly) with radiation therapy (C-RT) to those induced by radiation therapy alone (RT) on the immune function of patients with locally advanced cervical cancer.
In 8 prospectively randomized patients (i.e., 4 receiving RT vs. 4 receiving C-RT), lymphocyte populations including CD3+, CD4+ and CD8+ T-cell subsets, B cells (CD19+) and natural killer cells (CD56+, CD16+, CD3-) were studied before, during, and after therapy. Expression of the activation marker CD25 on CD3+ T cells, intracellular levels of perforin in CD8+ and CD56+ cells, and interferon-gamma (IFN-gamma) and IL-2 in CD4+ and CD8+ T cells was also measured. Finally, lymphoblast transformation and natural killer (NK) cytotoxic activity were assessed.
Both RT and C-RT significantly decreased the mean absolute number of all lymphocyte subsets compared to pretreatment levels (p > 0.001). However, no differences were detected in the characteristics or the magnitude of the lymphopenia induced by the two treatments. Both RT and C-RT increased similarly the percentages of CD25-positive lymphocytes (p > 0.001), and significantly decreased PHA-induced T-cell lymphoblast transformation (p > 0.001) and NK cytotoxic activity against K562 cells (p > 0.001). The percentage of perforin-positive and CD8+ T cells was not altered during either treatment, whereas the percentage of perforin-positive and CD56+ cells was significantly reduced during both treatments, and correlated with reduced cytotoxicity against K562 cells. The percentages of CD8+ IFN-gamma+ and CD4+ IFN-gamma+ T cells as well as that of CD8+ IL-2+ and CD4+ IL2+ T cells were not significantly altered by C-RT compared to RT alone. Finally, with both regimens, NK cells and B-cell numbers showed a more rapid recovery than T-cell numbers.
Administration of concurrent cisplatinum to radiation may synergistically increase cytotoxic effects of radiation on tumor cells but does not alter the magnitude and the characteristics of radiation-induced immunosuppression.
比较顺铂(40mg/m²/周)与放射治疗同步进行(C-RT)和单纯放射治疗(RT)对局部晚期宫颈癌患者免疫功能的影响。
8例前瞻性随机分组患者(即4例接受RT,4例接受C-RT),在治疗前、治疗期间和治疗后研究淋巴细胞群体,包括CD3⁺、CD4⁺和CD8⁺T细胞亚群、B细胞(CD19⁺)和自然杀伤细胞(CD56⁺、CD16⁺、CD3⁻)。还检测了CD3⁺T细胞上激活标志物CD25的表达、CD8⁺和CD56⁺细胞中穿孔素的细胞内水平以及CD4⁺和CD8⁺T细胞中干扰素-γ(IFN-γ)和IL-2的水平。最后,评估淋巴细胞转化和自然杀伤(NK)细胞毒性活性。
与治疗前水平相比,RT和C-RT均显著降低了所有淋巴细胞亚群的平均绝对数量(p>0.001)。然而,两种治疗引起的淋巴细胞减少的特征或程度未检测到差异。RT和C-RT均同样增加了CD25阳性淋巴细胞的百分比(p>0.001),并显著降低了PHA诱导的T细胞淋巴细胞转化(p>0.001)和对K562细胞的NK细胞毒性活性(p>0.001)。在两种治疗期间,穿孔素阳性和CD8⁺T细胞的百分比均未改变,而在两种治疗期间,穿孔素阳性和CD56⁺细胞的百分比均显著降低,且与对K562细胞的细胞毒性降低相关。与单纯RT相比,C-RT对CD8⁺IFN-γ⁺和CD4⁺IFN-γ⁺T细胞的百分比以及CD8⁺IL-2⁺和CD4⁺IL-2⁺T细胞的百分比均无显著改变。最后,两种方案中,NK细胞和B细胞数量的恢复均比T细胞数量更快。
同步给予顺铂和放射治疗可能协同增加放射对肿瘤细胞的细胞毒性作用,但不会改变放射诱导的免疫抑制的程度和特征。